Gilead Sciences's most recent trend suggests a bullish bias. One trading opportunity on Gilead Sciences is a Bull Put Spread using a strike $95.00 short put and a strike $90.00 long put offers a potential 25.94% return on risk over the next 35 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $95.00 by expiration. The full premium credit of $1.03 would be kept by the premium seller. The risk of $3.97 would be incurred if the stock dropped below the $90.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Gilead Sciences is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Gilead Sciences is bullish.
The RSI indicator is at 77.63 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Gilead Sciences
Gilead Announces Full 48-Week Results From Two Phase 3 Studies Evaluating Tenofovir Alafenamide (TAF) for Patients With Chronic Hepatitis B Infection
Fri, 15 Apr 2016 08:30:00 GMT
Business Wire – Gilead Sciences, Inc. today announced detailed 48-week results from two large Phase 3 clinical trials evaluating once-daily tenofovir alafenamide 25 mg in treatment-naïve and treatment-experienced adults with HBeAg-negative and HBeAg-positive chronic hepatitis B virus infection.
This is the most expensive drug in America
Thu, 14 Apr 2016 21:45:30 GMT
3 Momentum Stocks To Buy Now
Thu, 14 Apr 2016 20:10:08 GMT
Gilead (GILD) Stock Gained Today, Barclays Anticipates Q1 Earnings Beat
Thu, 14 Apr 2016 20:08:00 GMT
Also on Market Tamer…
Follow Us on Facebook